The Monkeypox vaccine has just been given the green light by the Federal Drug Administration (FDA) to be administered via intradermal injection. This method will allow healthcare professionals to get ...

PharmaJet presentation will highlight the results of recent immunization studies using needle-free intradermal (ID) delivery for polio immunization campaigns. Data reinforces how increased coverage, ...

The Tropis ® intradermal (ID) Needle-free Injection System overcomes the challenges of traditional Mantoux injection and can easily be integrated into commercial products and development projects.

In Cuba, the routine immunization (RI) schedule for polio consists of two doses of fIPV administered at 4 and 8 months of age administered intradermally with N/S. However, ID administration with N/S ...

NanoPass Technologies Ltd., a global leader in intradermal delivery solutions, will officially launch MicronJet™ 800 during IMCAS World 2026, taking place January 29 – 31, 2026, in Paris.

COSA MESA, Calif., Dec. 09, 2024 (GLOBE NEWSWIRE) -- AiViva Biopharma Inc., a clinical-stage biotechnology company, announced the receipt of FDA clearance for testing AIV001 (axitinib) by intradermal ...

A Rutgers Health survey of LGBTQ+ individuals in New York and New Jersey reveals that cisgender men, gay individuals and full-time employees had the highest rates of vaccination for Mpox, a viral ...

Needle-free Injection System - Stratis(R) - was used to deliver Scancell's iSCIB1+ DNA immunotherapy in combination with immune checkpoint inhibitors in the SCOPE Phase 2 trial. -- The Scancell ...

There were significantly fewer adverse events associated with needle-free Tropis ® intradermal (ID) delivery as compared to needle and syringe (N/S). Tropis ID delivery was preferred over N/S ID ...